Cancer of the skin: A forgotten problem in Eufrope

Annals of Oncology

Volumn 15, Issue 1, 2004, Pages 5-6

  Boyle, P ^a   Dore J F ^b   Autier, P ^c   Ringborg, U ^d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b INSERM   (France)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BASAL CELL CARCINOMA; BREAST CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COLON CANCER; EDITORIAL; EUROPE; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MALE; MALIGNANT LENTIGO; MATHEMATICAL MODEL; MELANOMA; MORBIDITY; NEW ZEALAND; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0942287957     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh032     Document Type: Editorial

References (19)

1. Elwood JM. Epidemiology and control of melanoma in white populations and in Japan. J Invest Dermatol 1989; 92: 214S-221S.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer-Base No. 5. Lyon, France: IARC Press, 2001.
3. Parkin DM, Whelan SL, Ferlay J et al. Cancer Incidence in Five Continents Vol VIII. Lyons, France: IARC, 2003.
4. Boyle P, Dore JF, Autier P et al. European Institute of Oncology Advisory Group Report on Prevention and Control of Melanoma. Eur J Cancer (in press).
5. Giles GG, Armstrong BK, Burton RC et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br Med J 1996; 312: 1121-1125.
6. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe, 1953-1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-126.
7. Boyle P, Smans M. Cancer Mortality Atlas of European Union, 1993-1997. Oxford, UK: Oxford University Press, 2003.
8. Pearce MS, Parker L, Cotterill SJ et al. Skin cancer in children and young adults: 28 years' experience from the Northern Young Persons's Malignant Disease Registry, UK. Melanoma Res 2003; 13: 421-426.
9. Boi S, Cristofolini M, Micciolo R et al. Epidemiology of Skin Tumours: Data from the Cutaneous Cancer Registry in Trentino, Italy. J Cutan Med Surg 2003; 16: 388-397.
10. de Rijke JM, Schouten LJ, Hillen HF et al. Cancer in the very elderly Dutch population. Cancer 2000; 89: 1121-1133.
11. Ceylan C, Ozturk G, Alper S. Non-melanomatous skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinico-pathological characteristics. J Dermatol 2003; 30: 123-131.
12. Levi F, Te VC, Randimbison L et al. Trends in Skin Cancer Incidence in Vaud: an update, 1976-1998. Eur J Cancer Prev 2001; 10: 371-373.
13. Wassberg C, Thorn M, Johansson AM et al. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol 2001; 81: 268-272.
14. Plesko I, Severi G, Obsitnikova A, Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma 2000; 47: 137-142.
15. Rosso S, Zanetti R, Martinez C et al. The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1447-1454.
16. Housman TS, Feldman SR, Williford PM et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J J Am Acad Dermatol 2003; 48: 425-429.
17. Quinn MJ, d'Onofrio A, Møller B et al. Cancer Mortality Trends in the EU and Acceeding States up to 2015. Ann Oncol 2003; 14: 1148-1152.
18. Boyle P, Autier P, Bartelink H et al. European Code Against Cancer and Scientific Justification: Third Version (2003). Ann Oncol 2003; 14: 973-1005.
19. Staples M, Marks R and Giles G. Trends in the incidence of non-melano-cytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-148.